| DAA1468 |
WW, C2 and coiled-coil domain containing 1 |
Molecular |
kidney |
Mouse |
Wwc1 |
11.0% Increase Gene Expression Level |
|
| DAA884 |
Widespread degeneration of glomerular blood vessels |
Physiological |
renal vasculature |
Human |
— |
— |
|
| DAA1472 |
vesicle-associated membrane protein 2 |
Molecular |
kidney |
Mouse |
Vamp2 |
39.0% Decrease Gene Expression Level |
|
| DAA896 |
Vasodilation induced by acetylcholine or sodium reduced |
Physiological |
renal vasculature |
Human |
— |
— |
|
| DAA900 |
Urine concentrating capacity decreases |
Physiological |
renal tubule |
Human |
— |
— |
|
| DAA1488 |
ubiquitin associated domain containing 1 |
Molecular |
kidney |
Mouse |
Ubac1 |
3.0% Decrease Gene Expression Level |
|
| DAA277 |
tyrosinase-related protein 1 |
Molecular |
kidney |
Human |
TYRP1 |
21.0% Decrease Gene Expression Level |
|
| DAA904 |
Transport maximum for glucose declines |
Physiological |
renal tubule |
Human |
— |
— |
|
| DAA1490 |
thymosin, beta 10 |
Molecular |
kidney |
Mouse |
Tmsb10 |
12.0% Increase Gene Expression Level |
|
| DAA901 |
telomere shortening |
Molecular |
kidney |
Human |
— |
— |
|
| DAA286 |
StAR-related lipid transfer (START) domain containing 8 |
Molecular |
kidney |
Human |
STARD8 |
14.0% Decrease Gene Expression Level |
|
| DAA902 |
specific activities of enzymes are reduced |
Molecular |
kidney |
Human |
— |
— |
|
| DAA1449 |
spastic paraplegia 21 homolog (human) |
Molecular |
kidney |
Mouse |
Spg21 |
5.0% Decrease Gene Expression Level |
|
| DAA268 |
solute carrier family 12 (sodium/chloride transporters), member 3 |
Molecular |
kidney |
Human |
SLC12A3 |
16.0% Decrease Gene Expression Level |
|
| DAA898 |
Sodium conservation decreased |
Physiological |
renal tubule |
Human |
— |
— |
|
| DAA282 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 |
Molecular |
kidney |
Human |
SERPINA5 |
11.0% Decrease Gene Expression Level |
|
| DAA1456 |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
Molecular |
kidney |
Mouse |
Sema4d |
4.0% Increase Gene Expression Level |
|
| DAA1451 |
RIKEN cDNA E030003E18 gene |
Molecular |
kidney |
Mouse |
E030003E18Rik |
11.0% Increase Gene Expression Level |
|
| DAA1448 |
RIKEN cDNA C730048C13 gene |
Molecular |
kidney |
Mouse |
C730048C13Rik |
7.0% Decrease Gene Expression Level |
|
| DAA1499 |
RIKEN cDNA C430014B12 gene |
Molecular |
kidney |
Mouse |
C430014B12Rik |
26.0% Increase Gene Expression Level |
|
| DAA1457 |
RIKEN cDNA 9530001N24 gene |
Molecular |
kidney |
Mouse |
9530001N24Rik |
3.0% Decrease Gene Expression Level |
|
| DAA1481 |
RIKEN cDNA 0610011F06 gene |
Molecular |
kidney |
Mouse |
0610011F06Rik |
6.0% Decrease Gene Expression Level |
|
| DAA276 |
Rh family, C glycoprotein |
Molecular |
kidney |
Human |
RHCG |
16.0% Decrease Gene Expression Level |
|
| DAA897 |
Response to antidiuretic hormone decreased |
Physiological |
renal tubule |
Human |
— |
— |
|
| DAA640 |
Renal failure |
Pathological |
kidney |
Human |
— |
SeriesMorbidity |
|